Yuanyuan Si

Yuanyuan Si

Auto-generated profile, based on publicly available information

Yuanyuan Si

Mechanistic Biology and Profiling, Assays, Profiling & Cell Sciences, BioPharmaceuticals R&D, AstraZeneca, Boston, US

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2021 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
YSYuanyuan Si
Yuanyuan Si
AKAshley M. Kretsch
Ashley M. Kretsch
LDLaura M. Daigh
Laura M. Daigh
MBMark J. Burk
Mark J. Burk
DMDouglas A. Mitchell
Douglas A. Mitchell

3 February 2023 in Biochemistry
Verified
Journal Article
Closed access
AKAshley M. Kretsch
Ashley M. Kretsch
MGMayuresh G. Gadgil
Mayuresh G. Gadgil
ADAdam J. DiCaprio
Adam J. DiCaprio
SBSusanna E. Barrett
Susanna E. Barrett
BKBryce L. Kille
Bryce L. Kille
DMDouglas A. Mitchell
Douglas A. Mitchell

11 March 2021 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
ALAndi Liu
Andi Liu
YSYuanyuan Si
Yuanyuan Si
SDShihui Dong
Shihui Dong
NMNilkamal Mahanta
Nilkamal Mahanta
HPHaley N. Penkala
Haley N. Penkala
DMDouglas A. Mitchell
Douglas A. Mitchell

22 April 2019 in ACS Infectious Diseases
Verified
Journal Article
Closed access
YSYuanyuan Si
Yuanyuan Si
SBSneha Basak
Sneha Basak
YLYong Li
Yong Li
JMJonathan Merino
Jonathan Merino
JIJames N. Iuliano
James N. Iuliano
PTPeter J. Tonge
Peter J. Tonge

26 March 2019 in Biochemistry
Verified
Journal Article
Open access
CEChristopher E. Evans
Christopher E. Evans
YSYuanyuan Si
Yuanyuan Si
JMJoe S. Matarlo
Joe S. Matarlo
YYYue Yin
Yue Yin
JFJarrod B. French
Jarrod B. French
DTDerek S. Tan
Derek S. Tan
N-Acyl sulfamoyladenosines (acyl-AMS) have been used extensively to inhibit adenylate-forming enzymes that are involved in a wide range of biological processes. These acyl-AMS inhibitors are nonhydrolyzable mimics of the cognate acyl adenylate intermediates that are bound tightly by adenylate-forming enzymes. However, the anionic acyl sulfamate moiety presents a pharmacological liability that may be detrimental to cell permeability and pharmacokinetic profiles. We have previously developed the acyl sulfamate OSB-AMS (1) as a potent inhibitor of the adenylate-forming enzyme MenE, an o-succinylbenzoate-CoA (OSB-CoA) synthetase that is required for bacterial menaquinone biosynthesis. Herein, we report the use of computational docking to develop novel, non-acyl sulfamate inhibitors of MenE. A m-phenyl ether-linked analogue (5) was found to be the most potent inhibitor (IC50 = 8 μM; Kd = 244 nM), and its X-ray co-crystal structure was determined to characterize its binding mode in comparison to the computational prediction. This work provides a framework for the development of potent non-acyl sulfamate inhibitors of other adenylate-forming enzymes in the future.

22 April 2025 in Journal of Biological Chemistry
Verified
Journal Article
Open access
RGRyan Guilbert
Ryan Guilbert
MCMaxime Couturier
Maxime Couturier
YSYuanyuan Si
Yuanyuan Si
DDDaniel O’ Donovan
Daniel O’ Donovan
DLDavid Longmire
David Longmire
AAArgyrides Argyrou
Argyrides Argyrou
Molecular glues are an emerging modality which induces or enhances an interaction between two proteins. Molecular glues can target proteins via proximity-induced degradation or sequestration and can, therefore, provide opportunities for therapeutic intervention to targets that cannot be modulated by traditional small molecule approaches. Due to their modest molecular weight, molecular glues may not encounter the bioavailability issues associated with PROTACs. Characterisation of molecular glues in hit finding and hit optimisation settings can be challenging, as both the affinity of the glue for the target protein and the resulting improvement in affinity between the proteins of interest need to be assessed in parallel. Here, we propose and validate a workflow to derive both key parameters from a classic concentration response experiment. Furthermore, we provide a method for the rational determination of optimum biochemical assay conditions to identify and characterise molecular glues.